The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9
Open accessAbstract
Adeno-associated virus serotype 8 (AAV8) is currently emerging as a powerful gene transfer vector, owing to its capability to efficiently transduce many different tissues in vivo. While this is believed to be in part due to its ability to uncoat more readily than other AAV serotypes such as AAV2, understanding all the processes behind AAV8 transduction is important for its application and optimal use in human gene therapy. Here, we provide the first report of a cellular receptor for AAV8, the 37/67-kDa laminin receptor (LamR). We document binding of LamR to AAV8 capsid proteins and intact virions in vitro and demonstrate its contribution to AAV8 transduction of cultured cells and mouse liver in vivo. We also show that LamR plays a role in transduction by three other closely related serotypes (AAV2, -3, and -9). Sequence and deletion analysis allowed us to map LamR binding to two protein subdomains predicted to be exposed on the AAV capsid exterior. Use of LamR, which is constitutively expressed in many clinically relevant tissues and is overexpressed in numerous cancers, provides a molecular explanation for AAV8's broad tissue tropism. Along with its robust transduction efficiency, our findings support the continued development of AAV8-based vectors for clinical applications in humans, especially for tumor gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070
αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Self-citationAdeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Wang, Z., Zhu, T., Qiao, C., Zhou, L., Wang, B., Zhang, J., Chen, C., Li, J., & Xiao, X. (2005) · Nature Biotechnology · doi:10.1038/nbt1073 · Cited by 608
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
Maheshri, N., Koerber, J. T., Kaspar, B. K., & Schaffer, D. V. (2006) · Nature Biotechnology · doi:10.1038/nbt1182 · Cited by 538 · cited 1×
“Of particular benefit is the feasibility to pseudotype recombinant AAV genomes (typically derived from the AAV serotype 2 [AAV2] prototype) with capsids from any of the over 100 identified naturally occurring human or nonhuman viral isolates (4, 8, 9, 11, 25) or with synthetic “designer” shells engineered via capsid D…”
BackgroundHuman fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., & Chiorini, J. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6884-6893.2001 · Cited by 427
Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer
Walters, R. W., Yi, S. M. P., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A., & Zabner, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101559200 · Cited by 363
High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells
Wang, K. S., Kuhn, R. J., Strauss, E. G., Ou, S., & Strauss, J. H. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4992-5001.1992 · Cited by 359
Thomas, C. E., Storm, T. A., Huang, Z., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3110-3122.2004 · Cited by 358
Self-citationIdentification of PDGFR as a receptor for AAV-5 transduction
Pasquale, G. D., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A., & Chiorini, J. A. (2003) · Nature Medicine · doi:10.1038/nm929 · Cited by 355 · cited 8×
“Similar to AAV2 and AAV6, soluble PDGF-AA and the anti-PDGFR antibody had no effect on AAV8 binding.”
BackgroundResultInfluentialGrimm, D., & Kay, M. (2003) · Current Gene Therapy · doi:10.2174/1566523034578285 · Cited by 350
Self-citationGrimm, D., Kay, M. A., & Kleinschmidt, J. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00095-9 · Cited by 344 · cited 1×
“or pDP6 (12), and pE5/V18 (9), respectively.”
Self-citationUnrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice
Nakai, H., Fuess, S., Storm, T. A., Muramatsu, S.-I., Nara, Y., & Kay, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.214-224.2005 · Cited by 327
Self-citationIdentification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor
Hundt, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5876 · Cited by 291
Wobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9281-9293.2000 · Cited by 273 · cited 1×
“Notably, the AAV2 homologous regions form loops on the capsid exterior, and their binding by neutralizing antibodies or their point mutagenesis blocks AAV2 cellular attachment and transduction (17, 37) (Fig.”
BackgroundThepparit, C., & Smith, D. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12647-12656.2004 · Cited by 258
Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection
Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., & Daida, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.609-614.2005 · Cited by 246 · cited 2×
“However, we hypothesize that since AAV2 uses at least four other receptors (16, 22, 28, 29), blocking one (LamR) might have only marginal effects on AAV2 binding.”
BackgroundMiao, C. H., Ohashi, K., Patijn, G. A., Meuse, L., Ye, X., Thompson, A. R., & Kay, M. A. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0075 · Cited by 246
Self-citationLochrie, M. A., Tatsuno, G. P., Christie, B., McDonnell, J. W., Zhou, S., Surosky, R., Pierce, G. F., & Colosi, P. (2006) · Journal of Virology · doi:10.1128/jvi.80.2.821-834.2006 · Cited by 201 · cited 1×
“Notably, the AAV2 homologous regions form loops on the capsid exterior, and their binding by neutralizing antibodies or their point mutagenesis blocks AAV2 cellular attachment and transduction (17, 37) (Fig.”
BackgroundNakai, H., Herzog, R. W., Hagstrom, J. N., Walter, J., Kung, S.-H., Yang, E. Y., Tai, S. J., Iwaki, Y., Kurtzman, G. J., Fisher, K. J., et al. (1998) · Blood · doi:10.1182/blood.v91.12.4600 · Cited by 188
Rabinowitz, J. E., Bowles, D. E., Faust, S. M., Ledford, J. G., Cunningham, S. E., & Samulski, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4421-4432.2004 · Cited by 171
Systemic tumor targeting and killing by Sindbis viral vectors
Tseng, J., Levin, B., Hurtado, A. M., Yee, H. T., de Castro, I. P., Jiménez, M., Shamamian, P. E., Jin, R., Novick, R. P., Pellicer, À., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt917 · Cited by 152
Production methods for gene transfer vectors based on adeno-associated virus serotypes
Grimm, D. (2002) · Methods · doi:10.1016/s1046-2023(02)00219-0 · Cited by 117
Self-citationChen, S., Kapturczak, M., Loiler, S., Zolotukhin, S., Glushakova, O. Y., Madsen, K., Samulski, R. J., Hauswirth, W. W., Campbell‐Thompson, M., Berns, K. I., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.235 · Cited by 112
Adeno-Associated Virus Types 5 and 6 Use Distinct Receptors for Cell Entry
Seiler, M. P., Miller, A. D., Zabner, J., & Halbert, C. L. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.10 · Cited by 104
Cloning of an Avian Adeno-Associated Virus (AAAV) and Generation of Recombinant AAAV Particles
Bossis, I., & Chiorini, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6799-6810.2003 · Cited by 103
Identification of mouse AAV capsid-specific CD8+ T cell epitopes
Sabatino, D. E., Mingozzi, F., Hui, D. J., Chen, H., Colosi, P., Ertl, H. C. J., & High, K. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.009 · Cited by 96
Cloning and Characterization of a Bovine Adeno-Associated Virus
Schmidt, M., Katano, H., Bossis, I., & Chiorini, J. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6509-6516.2004 · Cited by 84
Ardini, E., Sporchia, B., Pollegioni, L., Modugno, M., Ghirelli, C., Castiglioni, F., Tagliabue, E., & Ménard, S. (2002) · PubMed · Cited by 80
Sialic acid-dependent recognition of laminin and fibrinogen by Aspergillus fumigatus conidia
Bouchara, J. P., Sanchez, M., Chevailler, A., Marot-Leblond, A., Lissitzky, J. C., Tronchin, G., & Chabasse, D. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2717-2724.1997 · Cited by 79 · cited 1×
“Soluble laminin caused a twofold decrease in AAV5 binding, which was expected as laminin binds sialic acid, another AAV5 receptor (5).”
BackgroundUmeda, D., Tachibana, H., & Yamada, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.108 · Cited by 71
Attachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1
Blackburn, S. D., Steadman, R., & Johnson, F. B. (2005) · Archives of Virology · doi:10.1007/s00705-005-0650-6 · Cited by 57
Cited by
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
Gene therapy using adeno-associated virus vectors
Daya, S., & Berns, K. I. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-08 · Cited by 926
Grimm, D., Lee, J. S., Wang, L., Desai, T., Akache, B., Storm, T. A., & Kay, M. A. (2008) · Journal of Virology · doi:10.1128/jvi.00254-08 · Cited by 696
Self-citationAschauer, D. F., Kreuz, S., & Rumpel, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076310 · Cited by 522
Metadata
- Authors
- Akache, B., Grimm, D., Pandey, K., Yant, S. R., Xu, H., & Kay, M. A.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-10
- Volume
- 80
- Issue
- 19
- Pages
- 9831-9836
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2170490863
- Cited by
- 430
- References
- 35
- FWCI
- 13.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.